CA3071937A1 - Process and system for utilizing energy to treat biological tissue - Google Patents
Process and system for utilizing energy to treat biological tissue Download PDFInfo
- Publication number
- CA3071937A1 CA3071937A1 CA3071937A CA3071937A CA3071937A1 CA 3071937 A1 CA3071937 A1 CA 3071937A1 CA 3071937 A CA3071937 A CA 3071937A CA 3071937 A CA3071937 A CA 3071937A CA 3071937 A1 CA3071937 A1 CA 3071937A1
- Authority
- CA
- Canada
- Prior art keywords
- tissue
- treatment
- para
- time
- radiation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims abstract description 59
- 230000008569 process Effects 0.000 title claims abstract description 36
- 238000011282 treatment Methods 0.000 claims abstract description 307
- 230000005855 radiation Effects 0.000 claims abstract description 134
- 230000002207 retinal effect Effects 0.000 claims abstract description 71
- 230000001225 therapeutic effect Effects 0.000 claims abstract description 29
- 102000002812 Heat-Shock Proteins Human genes 0.000 claims description 197
- 108010004889 Heat-Shock Proteins Proteins 0.000 claims description 197
- 230000004913 activation Effects 0.000 claims description 50
- 230000000451 tissue damage Effects 0.000 claims description 14
- 231100000827 tissue damage Toxicity 0.000 claims description 14
- 230000004936 stimulating effect Effects 0.000 claims description 6
- 210000001519 tissue Anatomy 0.000 description 186
- 230000006378 damage Effects 0.000 description 56
- 210000001525 retina Anatomy 0.000 description 46
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 44
- 238000001994 activation Methods 0.000 description 41
- 238000010521 absorption reaction Methods 0.000 description 39
- 210000004027 cell Anatomy 0.000 description 37
- 230000000694 effects Effects 0.000 description 30
- 230000003287 optical effect Effects 0.000 description 27
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 23
- 102000004169 proteins and genes Human genes 0.000 description 22
- 108090000623 proteins and genes Proteins 0.000 description 22
- 210000003583 retinal pigment epithelium Anatomy 0.000 description 22
- 230000006870 function Effects 0.000 description 21
- 230000001965 increasing effect Effects 0.000 description 20
- 101100506686 Arabidopsis thaliana HSFA1B gene Proteins 0.000 description 18
- 101150017616 Hsf3 gene Proteins 0.000 description 18
- 101100071480 Oryza sativa subsp. japonica HSFA1 gene Proteins 0.000 description 18
- 230000000254 damaging effect Effects 0.000 description 18
- 230000007246 mechanism Effects 0.000 description 18
- 230000006399 behavior Effects 0.000 description 15
- 230000008901 benefit Effects 0.000 description 15
- 241000894007 species Species 0.000 description 15
- 101100421857 Caenorhabditis elegans sod-2 gene Proteins 0.000 description 14
- 230000000649 photocoagulation Effects 0.000 description 14
- 230000007423 decrease Effects 0.000 description 12
- 230000001413 cellular effect Effects 0.000 description 11
- 108020004999 messenger RNA Proteins 0.000 description 11
- 230000006872 improvement Effects 0.000 description 10
- 230000008439 repair process Effects 0.000 description 10
- 230000035939 shock Effects 0.000 description 10
- 238000009792 diffusion process Methods 0.000 description 8
- 238000004519 manufacturing process Methods 0.000 description 8
- 206010012688 Diabetic retinal oedema Diseases 0.000 description 6
- 208000017442 Retinal disease Diseases 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- 210000000805 cytoplasm Anatomy 0.000 description 6
- 201000011190 diabetic macular edema Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 230000003902 lesion Effects 0.000 description 6
- 230000035515 penetration Effects 0.000 description 6
- 230000005451 protein repair Effects 0.000 description 6
- 206010012689 Diabetic retinopathy Diseases 0.000 description 5
- 230000001427 coherent effect Effects 0.000 description 5
- 230000001086 cytosolic effect Effects 0.000 description 5
- 239000000835 fiber Substances 0.000 description 5
- 230000014509 gene expression Effects 0.000 description 5
- 238000013021 overheating Methods 0.000 description 5
- 239000000790 retinal pigment Substances 0.000 description 5
- 230000000638 stimulation Effects 0.000 description 5
- 230000004393 visual impairment Effects 0.000 description 5
- 102000004127 Cytokines Human genes 0.000 description 4
- 108090000695 Cytokines Proteins 0.000 description 4
- 108020004414 DNA Proteins 0.000 description 4
- 238000002835 absorbance Methods 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 230000005779 cell damage Effects 0.000 description 4
- 208000037887 cell injury Diseases 0.000 description 4
- 230000001066 destructive effect Effects 0.000 description 4
- 230000005670 electromagnetic radiation Effects 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 231100000518 lethal Toxicity 0.000 description 4
- 230000001665 lethal effect Effects 0.000 description 4
- 239000000049 pigment Substances 0.000 description 4
- 230000000750 progressive effect Effects 0.000 description 4
- 230000002441 reversible effect Effects 0.000 description 4
- 238000013518 transcription Methods 0.000 description 4
- 230000035897 transcription Effects 0.000 description 4
- 230000004304 visual acuity Effects 0.000 description 4
- 230000000007 visual effect Effects 0.000 description 4
- 208000003569 Central serous chorioretinopathy Diseases 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 206010064930 age-related macular degeneration Diseases 0.000 description 3
- 230000003915 cell function Effects 0.000 description 3
- 238000004925 denaturation Methods 0.000 description 3
- 230000036425 denaturation Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 208000002780 macular degeneration Diseases 0.000 description 3
- 230000001404 mediated effect Effects 0.000 description 3
- 239000013307 optical fiber Substances 0.000 description 3
- 238000001126 phototherapy Methods 0.000 description 3
- 201000007914 proliferative diabetic retinopathy Diseases 0.000 description 3
- 230000002035 prolonged effect Effects 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 230000003252 repetitive effect Effects 0.000 description 3
- 230000037390 scarring Effects 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 239000013638 trimer Substances 0.000 description 3
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- 102000053602 DNA Human genes 0.000 description 2
- 208000001344 Macular Edema Diseases 0.000 description 2
- 206010025415 Macular oedema Diseases 0.000 description 2
- 208000022873 Ocular disease Diseases 0.000 description 2
- 206010057430 Retinal injury Diseases 0.000 description 2
- 206010038923 Retinopathy Diseases 0.000 description 2
- 206010053615 Thermal burn Diseases 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 230000003466 anti-cipated effect Effects 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000027455 binding Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 230000004637 cellular stress Effects 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 230000008021 deposition Effects 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 230000005611 electricity Effects 0.000 description 2
- 208000030533 eye disease Diseases 0.000 description 2
- 230000017525 heat dissipation Effects 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 230000001976 improved effect Effects 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 201000010230 macular retinal edema Diseases 0.000 description 2
- 239000000178 monomer Substances 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 231100001160 nonlethal Toxicity 0.000 description 2
- 230000036407 pain Effects 0.000 description 2
- 230000000737 periodic effect Effects 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 231100000241 scar Toxicity 0.000 description 2
- 210000003491 skin Anatomy 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 230000036575 thermal burns Effects 0.000 description 2
- 230000001052 transient effect Effects 0.000 description 2
- 206010003694 Atrophy Diseases 0.000 description 1
- 201000004569 Blindness Diseases 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- 208000024304 Choroidal Effusions Diseases 0.000 description 1
- 208000005590 Choroidal Neovascularization Diseases 0.000 description 1
- 206010008783 Choroidal detachment Diseases 0.000 description 1
- 206010060823 Choroidal neovascularisation Diseases 0.000 description 1
- 208000032544 Cicatrix Diseases 0.000 description 1
- 102000014824 Crystallins Human genes 0.000 description 1
- 108010064003 Crystallins Proteins 0.000 description 1
- 230000004568 DNA-binding Effects 0.000 description 1
- 206010052804 Drug tolerance Diseases 0.000 description 1
- 101000990176 Escherichia coli (strain K12) Protein/nucleic acid deglycase 1 Proteins 0.000 description 1
- 206010020843 Hyperthermia Diseases 0.000 description 1
- 208000001140 Night Blindness Diseases 0.000 description 1
- 206010038848 Retinal detachment Diseases 0.000 description 1
- 206010038895 Retinal scar Diseases 0.000 description 1
- 208000007014 Retinitis pigmentosa Diseases 0.000 description 1
- 208000036038 Subretinal fibrosis Diseases 0.000 description 1
- 206010046851 Uveitis Diseases 0.000 description 1
- 206010047571 Visual impairment Diseases 0.000 description 1
- 208000034698 Vitreous haemorrhage Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 208000038016 acute inflammation Diseases 0.000 description 1
- 230000006022 acute inflammation Effects 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 230000010455 autoregulation Effects 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000008512 biological response Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001775 bruch membrane Anatomy 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 210000003855 cell nucleus Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 208000037976 chronic inflammation Diseases 0.000 description 1
- 230000006020 chronic inflammation Effects 0.000 description 1
- 230000007012 clinical effect Effects 0.000 description 1
- 201000008615 cone dystrophy Diseases 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- 230000009849 deactivation Effects 0.000 description 1
- 230000003412 degenerative effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000003292 diminished effect Effects 0.000 description 1
- 208000011325 dry age related macular degeneration Diseases 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 238000004880 explosion Methods 0.000 description 1
- 238000002839 fiber optic waveguide Methods 0.000 description 1
- 230000001497 fibrovascular Effects 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 230000002008 hemorrhagic effect Effects 0.000 description 1
- 230000036031 hyperthermia Effects 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000002647 laser therapy Methods 0.000 description 1
- 238000013532 laser treatment Methods 0.000 description 1
- 238000002690 local anesthesia Methods 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 238000013533 micropulse laser treatment Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000000633 nuclear envelope Anatomy 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 230000000886 photobiology Effects 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 230000006432 protein unfolding Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000000246 remedial effect Effects 0.000 description 1
- 230000000452 restraining effect Effects 0.000 description 1
- 230000004264 retinal detachment Effects 0.000 description 1
- 230000004243 retinal function Effects 0.000 description 1
- 230000004286 retinal pathology Effects 0.000 description 1
- 208000004644 retinal vein occlusion Diseases 0.000 description 1
- 230000037387 scars Effects 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 238000004088 simulation Methods 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 238000007725 thermal activation Methods 0.000 description 1
- 230000000930 thermomechanical effect Effects 0.000 description 1
- 208000037816 tissue injury Diseases 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 238000011269 treatment regimen Methods 0.000 description 1
- 230000004382 visual function Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
- A61N5/0625—Warming the body, e.g. hyperthermia treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/007—Methods or devices for eye surgery
- A61F9/008—Methods or devices for eye surgery using laser
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/067—Radiation therapy using light using laser light
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/007—Methods or devices for eye surgery
- A61F9/008—Methods or devices for eye surgery using laser
- A61F2009/00861—Methods or devices for eye surgery using laser adapted for treatment at a particular location
- A61F2009/00863—Retina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/007—Methods or devices for eye surgery
- A61F9/008—Methods or devices for eye surgery using laser
- A61F2009/00897—Scanning mechanisms or algorithms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0635—Radiation therapy using light characterised by the body area to be irradiated
- A61N2005/0643—Applicators, probes irradiating specific body areas in close proximity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
- A61N2005/0659—Radiation therapy using light characterised by the wavelength of light used infrared
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
- A61N2005/0662—Visible light
- A61N2005/0663—Coloured light
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pathology (AREA)
- Radiology & Medical Imaging (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Ophthalmology & Optometry (AREA)
- Surgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Radiation-Therapy Devices (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
- Cultivation Of Seaweed (AREA)
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15/813,645 | 2017-11-15 | ||
| US15/813,645 US10357398B2 (en) | 2016-03-21 | 2017-11-15 | System and process for treatment of myopia |
| US15/918,487 US10874873B2 (en) | 2012-05-25 | 2018-03-12 | Process utilizing pulsed energy to heat treat biological tissue |
| US15/918,487 | 2018-03-12 | ||
| US16/038,561 US10596389B2 (en) | 2012-05-25 | 2018-07-18 | Process and system for utilizing energy to treat biological tissue |
| US16/038,561 | 2018-07-18 | ||
| PCT/US2018/042833 WO2019099068A1 (en) | 2017-11-15 | 2018-07-19 | Process and system for utilizing energy to treat biological tissue |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3071937A1 true CA3071937A1 (en) | 2019-05-23 |
Family
ID=66538738
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3071937A Pending CA3071937A1 (en) | 2017-11-15 | 2018-07-19 | Process and system for utilizing energy to treat biological tissue |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP3703815A1 (ja) |
| JP (1) | JP7130271B2 (ja) |
| CN (1) | CN111343936B (ja) |
| AU (1) | AU2018369022B2 (ja) |
| BR (1) | BR112020009238A2 (ja) |
| CA (1) | CA3071937A1 (ja) |
| WO (1) | WO2019099068A1 (ja) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115501493A (zh) * | 2019-06-06 | 2022-12-23 | 中山大学中山眼科中心 | 一种增加眼底血流和代谢率的方法 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5951596A (en) * | 1991-07-01 | 1999-09-14 | Laser Biotherapy Inc | Biological tissue stimulation by optical energy |
| JP3977017B2 (ja) * | 2001-02-01 | 2007-09-19 | 株式会社ニデック | レーザ治療装置 |
| JP3613634B2 (ja) * | 2001-11-06 | 2005-01-26 | 得一郎 長谷川 | 視力矯正装置 |
| NZ565954A (en) * | 2005-07-27 | 2012-03-30 | Univ Florida | Use of heat shock inducing compound and an agent that increases stem cell mobilization int he manufacture of a medicament to treat ocular disease |
| WO2008013985A2 (en) * | 2006-07-27 | 2008-01-31 | University Of Florida | Use of heat shock activators for tissue regeneration |
| US20100049180A1 (en) * | 2007-10-19 | 2010-02-25 | Lockheed Martin Corporation | System and method for conditioning animal tissue using laser light |
| JP4996237B2 (ja) * | 2006-12-26 | 2012-08-08 | 株式会社ニデック | 眼科用レーザ治療装置 |
| US20110306919A1 (en) * | 2008-01-18 | 2011-12-15 | Latina Mark A | Selective Photostimulation to Induce Cell Proliferation |
| EP2729215A4 (en) * | 2011-07-10 | 2015-04-15 | Guided Therapy Systems Llc | METHODS AND SYSTEMS FOR ULTRASONIC TREATMENT |
| US10953241B2 (en) * | 2012-05-25 | 2021-03-23 | Ojai Retinal Technology, Llc | Process for providing protective therapy for biological tissues or fluids |
| US10531908B2 (en) * | 2012-05-25 | 2020-01-14 | Ojai Retinal Technology, Llc | Method for heat treating biological tissues using pulsed energy sources |
| US10278863B2 (en) * | 2016-03-21 | 2019-05-07 | Ojai Retinal Technology, Llc | System and process for treatment of myopia |
| US10219947B2 (en) * | 2012-05-25 | 2019-03-05 | Ojai Retinal Technology, Llc | System and process for retina phototherapy |
| US9381115B2 (en) | 2012-05-25 | 2016-07-05 | Ojai Retinal Technology, Llc | System and process for retina phototherapy |
| JP2018503432A (ja) * | 2015-01-28 | 2018-02-08 | オーハイ レチナル テクノロジー，エルエルシー | 慢性の進行性網膜疾患のための閾値以下のマイクロパルスレーザー予防治療 |
| WO2016122752A1 (en) * | 2015-01-28 | 2016-08-04 | Ojai Retinal Technology, Llc | Pulsating electromagnetic and ultrasound therapy for stimulating targeted heat shock proteins and facilitating protein repair |
-
2018
- 2018-07-19 EP EP18877518.3A patent/EP3703815A1/en active Pending
- 2018-07-19 JP JP2020507031A patent/JP7130271B2/ja active Active
- 2018-07-19 AU AU2018369022A patent/AU2018369022B2/en active Active
- 2018-07-19 BR BR112020009238-0A patent/BR112020009238A2/pt unknown
- 2018-07-19 CN CN201880073796.XA patent/CN111343936B/zh active Active
- 2018-07-19 WO PCT/US2018/042833 patent/WO2019099068A1/en active Application Filing
- 2018-07-19 CA CA3071937A patent/CA3071937A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN111343936A (zh) | 2020-06-26 |
| JP7130271B2 (ja) | 2022-09-05 |
| BR112020009238A2 (pt) | 2020-10-20 |
| JP2021502834A (ja) | 2021-02-04 |
| AU2018369022A1 (en) | 2020-03-12 |
| EP3703815A4 (en) | 2020-09-09 |
| CN111343936B (zh) | 2024-03-22 |
| EP3703815A1 (en) | 2020-09-09 |
| WO2019099068A1 (en) | 2019-05-23 |
| AU2018369022B2 (en) | 2023-09-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10709607B2 (en) | System and process for treatment of myopia | |
| US10285859B2 (en) | System for performing retina photostimulation | |
| AU2021215167B2 (en) | System and process for retina phototherapy | |
| AU2017412681B2 (en) | System and process for treatment of myopia | |
| US10596389B2 (en) | Process and system for utilizing energy to treat biological tissue | |
| AU2018369022B2 (en) | Process and system for utilizing energy to treat biological tissue | |
| EP4196032A1 (en) | Retinal irradiation system and method to improve ocular function and health in the normally aging eye | |
| US20210339039A1 (en) | Retinal phototherapy system and method having fixed parameters | |
| AU2022291348A1 (en) | Retinal phototherapy system and method having fixed parameters | |
| US20210339044A1 (en) | Retinal irradiation system and method to improve ocular function and health in the normally aging eye | |
| AU2022287887A1 (en) | Retinal irradiation system and method to improve ocular function and health in the normally aging eye | |
| CA3051444A1 (en) | Process utilizing pulsed energy to heat treat biological tissue | |
| CN117479907A (zh) | 改善正常衰老眼睛的眼功能和健康的视网膜照射系统和方法 | |
| CA3091103A1 (en) | System and process of utilizing energy for treating biological tissue |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20220909 |
|
| EEER | Examination request |
Effective date: 20220909 |
|
| EEER | Examination request |
Effective date: 20220909 |
|
| EEER | Examination request |
Effective date: 20220909 |